Program Overview:

The joint providership of The University of Cincinnati and Focus Medical Communications presents a virtual program focused on practical and clinically pertinent data and information from EULAR and ACR for the community physician and APPs.

 

Target Audience:

Rheumatologists, NPs, PAs, and other HCPs who treat rheumatic diseases.

Educational Objectives:
After completing this activity, the participant should be better able to:

• Analyze implications of early diagnosis and treatment in various rheumatic conditions.

• Evaluate optimal evidence-based treatment strategies for patients with rheumatic diseases.

• Apply personalized approaches to the care of patients with rheumatologic conditions.

• Examine the role and benefits of biosimilars in clinical practice.

Accreditation Statement:

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Cincinnati and the Focus Medical Communications. The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians.

 

The University of Cincinnati designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Disclosure of Relevant Financial Relationships:

In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education and the University of Cincinnati policy, all faculty, planning committee members, and other individuals, who are in a position to control content, are required to disclose all relationships with ineligible companies* (commercial interests) within the last 24 months. All educational materials are reviewed for fair balance, scientific objectivity, and levels of evidence. The ACCME requires us to disqualify from involvement in the planning and implementation of accredited continuing education any individuals (1) who refuse to provide this information or (2) whose conflicts of interests cannot be mitigated.

 

*Companies that are ineligible to be accredited in the ACCME System (ineligible companies) are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

 

All relevant relationships have been mitigated prior to the commencement of this activity.

 

All additional planning committee members, the University of Cincinnati staff and the Focus Medical Communications staff have no relationships to disclose.

 

Disclaimer:

The opinions expressed during the educational activity are those of the faculty and do not necessarily represent the views of the University of Cincinnati. The information is presented for the purpose of advancing the attendees’ professional development.

 

Off-Label Disclosure Statement:

Faculty members are required to inform the audience when they are discussing off-label, unapproved uses of devices and drugs. Physicians should consult full prescribing information before using any product mentioned during this educational activity.

 

Fee information:

There is no fee for this educational activity.